Is azithromycin able to control Toxoplasma gondii infection in human villous explants?
In conclusion, these results suggest that azithromycin may be defined as an effective alternative drug to control T. gondii infection at the fetal-maternal interface.
A putative human homologue of murine PIF and its role in human cancer cachexia cannot be verified.